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Abstract
OBJECTIVES: Sleeve resection is the operation of choice in patients with centrally located tumours, in order to avoid a pneumonec-
tomy. Most surgeons protect the bronchial anastomoses with tissue to prevent insufﬁciencies. The purpose of this study is to report on
outcome of unwrapped bronchial anastomoses, especially after neoadjuvant chemo- or chemoradiotherapy.
METHODS: Between 2000 and 2010, 103 patients [59 years (range 16–80), 40 females] underwent bronchial sleeve resections without
coverage of the anastomosis with a tissue ﬂap. We retrospectively reviewed the data for morbidity, mortality and survival, especially
with regard to the type of resection, neoadjuvant therapy and stage.
RESULTS: Sleeve lobectomy was performed in 88, sleeve bilobectomy in 8, sleeve pneumonectomy in 4 and sleeve resection of the
main bronchus in 3 patients. Twenty-seven patients had a combined vascular sleeve resection. Neoadjuvant chemotherapy was per-
formed in 20 and radiochemotherapy in 5 patients. Non-small cell lung cancer (NSCLC) was present in 76 patients (squamous cell car-
cinoma in 44, adenocarcinoma in 24, large cell carcinoma in 6 and mixed cell in 2) and neuroendocrine tumour in 20 and other
histological types in 7 patients. The pathologic tumour stage in NSCLC was stage I in 26, stage II in 26, stage IIIA in 16, stage IIIB in 7
and stage IV in 1 patient. There were no anastomotic complications, especially no ﬁstulas. One patient developed narrowing of the
intermediate bronchus without need for intervention. Twenty-four patients had early postoperative complications, including 11
surgery-related complications (air leakage, nerve injury, haemothorax or mediastinal emphysema). The 30-day mortality was 3% (one
patient died due to heart failure and two with multiorgan failure). The 5-year survival rate was 63% in NSCLC patients and 86% in neu-
roendocrine tumour patients.
CONCLUSIONS: Sleeve resection without wrapping the bronchial anastomoses with a tissue ﬂap is safe even in patients who underwent
neoadjuvant chemo- or chemoradiotherapy. Therefore, wrapping of the bronchial anastomoses is not routinely mandatory.
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INTRODUCTION
Since Price-Thomas [1] ﬁrst introduced bronchial sleeve resec-
tion in 1947 and Allison [2] applied it for the treatment of a
bronchogenic carcinoma in 1954, this procedure has gained a
deﬁnite role in the treatment of centrally located bronchopul-
monary neoplasms [3, 4].
Issues of concern that led to a gradual introduction of this
technique into common surgical use included the possible risk
of local recurrence and of disadvantage in long-term survival
and the complications related to the bronchial anastomosis.
Recent studies demonstrated that in sleeve resections, there is
no evidence of increased risk of local recurrence after sleeve
resection, and long-term survival is similar or better than after
pneumonectomy. Furthermore, this technique can be performed
with a low risk of bronchial anastomotic complications [5–9].
In order to obtain adequate blood support to the suture line
and to prevent anastomotic complications, the coverage of the
bronchial anastomosis with an autogenous tissue pedicled ﬂap
has become a common and recommended procedure [10]. The
wrapping of the anastomosis has been described with pericar-
dial, pleural or intercostal muscle ﬂaps, with mediastinal fat,
omentum or internal mammary artery pedicles [11–13].
Wrapping the bronchial anastomosis with either omentum or
an internal mammary artery pedicle was also routinely per-
formed in lung transplantations in the late 1980s and early
1990s, but several studies demonstrated that it is not mandatory
for bronchial healing [14, 15].
In our centre, we routinely performed bronchial sleeve resec-
tions without wrapping the anastomosis, also in patients who
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had neoadjuvant chemo- or chemoradiotherapy. In this study,
we retrospectively analysed the postoperative mortality, the
long-term survival and the incidence of short- and long-term
morbidity, especially with regard to the type of resection,
neoadjuvant therapy and stage, in order to assess whether wrap-
ping the bronchial anastomosis is still an essential procedure in
course of sleeve resections or not.
PATIENTS AND METHODS
In this retrospective study, we included 103 consecutive patients
who underwent bronchial sleeve resections without wrapping
the anastomosis, between January 2000 and April 2010. Patients
operated on cardiopulmonary bypass were excluded from this
analysis.
There were 63 males and 40 females with a median age at
operation of 59 years (range 16–80). The preoperative evalu-
ation of the patients included physical examination, chest radi-
ography, pulmonary function tests, blood examinations,
electrocardiography, computed tomography (CT) of the chest
and upper abdomen and positron emission tomography-CT
(PET-CT). PET-CT-positive lymph nodes were examined
through endobronchial ultrasonography (EBUS). Only if EBUS
was negative and a high suspicion for lymph nodal metastases
was present, mediastinoscopy was performed. Preoperative CT
scans or bronchoscopy often identiﬁed a possible candidate
for a sleeve resection, but the ﬁnal decision was always taken
intraoperatively.
All patients underwent a double-lumen tracheal intubation
and a standard anterolateral thoracotomy. To evaluate the
airway anatomy and the tumour invasion, ﬂexible bronchoscopy
was carried out immediately before and during the operation.
The bronchus was divided with a sharp knife obtaining straight
margins distant from the tumour. Frozen sections of the resected
margins were analysed to ensure complete resection. The
end-to-end bronchial anastomosis was performed using a con-
tinuous absorbable running 4–0 polydioxanone suture (Ethicon,
Inc., Somerville, NJ, USA) on the membranous airway wall. The
cartilaginous part was anastomosed with an interrupted suture
technique, and the knots were placed outside the lumen and
tied at completion of the anastomosis comparable to the tech-
nique in lung transplantation. Care was taken to keep the peri-
bronchial tissue intact, and systematic lymph node dissection
was carried out in all neoplastic patients. The wrapping of the
anastomotic bronchial suture with any kind of autogenous tissue
pedicled ﬂap was not performed. When necessary, arterial
sleeve resection was carried out, using a 5–0 polypropylene
running suture (Prolene, Ethicon, Inc.). At the end of the proced-
ure, the bronchial anastomosis was controlled with ﬂexible bron-
choscopy and cleaned up from clots and secretions.
The follow-up of the patients was started from the date of the
operation to the time of death or to the last observation. Data
were collected from the hospital database and, for those who
were not routinely followed up, from the referring physicians,
the patients themselves and their families.
Patient records were collected for age, gender, type of oper-
ation, histology, stage of the disease at operation time, neoadju-
vant therapy, short- and long-term postoperative complications
and survival. Postoperative mortality was considered as death
within 30 and 90 days from the operation.
RESULTS
Out of 992 resections, sleeve lobectomy was performed in 88
patients, out of them 49 were of the right upper lobe, 28 of the
left upper lobe, 6 of the left lower lobe and 5 of the middle
lobe. Eight sleeve bilobectomies, four sleeve pneumonectomies
and three main bronchus sleeve resections were also performed
(Table 1). In 27 (26%) patients, a concomitant vascular sleeve re-
section was carried out.
Twenty-ﬁve (24%) patients received preoperative platinum-
based induction therapy. All of these patients had neoadjuvant
chemotherapy (two to six cycles), and ﬁve (20%) of them
received concurrent chemoradiotherapy (three to six cycles of
chemotherapy plus 44–66 Gy of radiotherapy).
Histological examination showed a non-small cell lung cancer
(NSCLC) in 76 patients (squamous cell carcinoma in 44, adeno-
carcinoma in 24, large cell carcinoma in 6 and mixed cell in 2), a
pulmonary neuroendocrine tumour in 20 (15 typical carcinoid
tumours and 5 atypical carcinoid tumours) and other histological
types in 7 patients (Table 2).
Among the 76 NSCLC patients, the TNM classiﬁcation identi-
ﬁed 26 stage I disease (10 IA and 16 IB), 26 stage II disease
(9 IIA and 17 IIB), 16 stage IIIA disease, 7 stage IIIB disease and
1 stage IV disease (with resected synchronous brain metastasis).
Short- and long-term morbidity is shown in Table 3. There
was no anastomosis-related complication, especially no ﬁstulas.
A total of 24 (23%) patients experienced 27 early postoperative
complications. Three patients (3%) presented long-term compli-
cations, including two post-pneumonectomy syndromes, which
were successfully treated with the implantation of prostheses,
and one intermediate bronchus narrowing. This mild stenosis
didn’t need any surgical treatment, and the patient died after 23
months because of a pulmonary embolism.
The 30-day mortality was 2.9% (three patients) and the 90-day
mortality was 4.8% (ﬁve patients). One patient died on the
seventh postoperative day because of heart failure. Two patients
died because of multiorgan failure: one on the 9th and one on
the 22nd postoperative day. Two patients received adjuvant
radiotherapy of the mediastinum and tree adjuvant chemother-
apy. Eight patients developed a local recurrence during follow-
up, out of them three patients had a completion pneumonec-
tomy, two patients radiotherapy and three patients a second-line
chemotherapy.
Table 1: Type of bronchial sleeve resection
Type of resection No. of patients (%)
Lobectomy 88 (85.4)
Right upper lobe 49
Left upper lobe 28
Left lower lobe 6
Middle lobe 5
Bilobectomy 8 (7.8)
Upper 2
Lower 4
Right pneumonectomy 4 (3.8)
Main bronchus resection 3 (2.9)
Right 1
Left 2
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The mean postoperative hospitalization time was 9.7 days.
Follow-up periods ranged from 1 to 123 months, with a mean of
41 months, and were complete for 102 patients (99%). There
was one loss of follow-up after 2 months.
In the 76 NSCLC patients, the median survival was 81 ± 11
months (95% conﬁdence interval: 59–102), and the 5-year
survival rate was 63%. The 5-year survival rate in the 20
neuroendocrine tumour patients was 86% (Figs 1–3, computed
Kaplan–Meier curves).
DISCUSSION
Bronchial sleeve resection has nowadays become an established
alternative to pneumonectomy for patients with centrally
located NSCLC, regardless of their pulmonary function. The
Table 2: Histological diagnosis
Histology No. of patients (%)
NSCLC 76 (73.7)
Squamous cell carcinoma 44
Adenocarcinoma 24
Large cell carcinoma 6
Mixed NSCLC 2
Pulmonary neuroendocrine tumours 20 (19.4)
Typical carcinoid tumours 15
Atypical carcinoid tumours 5
Other histological types 7 (6.7)
Metastases 3
Small cell carcinoma 2
Endobronchial lipoma 1
Sarcoma 1
Table 3: Short- and long-term complications
Type of complication No. of patients
Short-term complications 27
Prolonged air leak 5
Laryngeal nerve palsy 2
Phrenic nerve palsy 1
Haemothorax 2
Mediastinal emphysema 1
Pneumonia 3
Atelectasis 1
Atrial fibrillation 8
ARDS 1
Sepsis 2
Heart failure 1
Long-term complications 3
Post-pneumonectomy syndrome 2
Bronchial stenosis 1
Figure 2: Survival curve in patients with neuroendocrine tumours.
Figure 1: Survival curve related to stage in patients with NSCLC.
Figure 3: Survival curve in patients with NSCLC.
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postoperative mortality and morbidity after sleeve lobectomy
have been demonstrated to be equal or even better than after
pneumonectomy, with a related better quality of life [5–9].
Bronchial sleeve resection is currently performed in 5–8% of
patients with resectable lung cancer [16], but rates up to 13%
have been reported [7].
In a recent meta-analysis, Ferguson and Lehman [8] reported a
weighted mean operative mortality of 4.1% (conﬁdence interval:
2.3–5.9%). Yildizeli et al. [17] also registered an operative mortal-
ity of 4.1% after sleeve resection, and Merritt et al. [13] had a
30-day mortality of 2%. In our study, we registered an overall
30-day mortality of 2.9%, which is in the lower range of literature
(Table 4).
Sleeve resections are technically more demanding than stand-
ard lobectomies, and speciﬁc complications are related to the
bronchial anastomosis. Its failure can lead to dehiscence and
bronchopleural ﬁstula, stenosis or bronchovascular ﬁstula: situa-
tions that can often require completion pneumonectomy. The
protection of the bronchial anastomosis is a subject of contro-
versy. Many authors consider wrapping the bronchial anasto-
mosis with an autogenous tissue pedicled ﬂap as a fundamental
procedure to reduce the incidence of severe anastomotic com-
plications [18]. Though performing the wrapping of the bronchial
anastomosis, Yildizeli et al. [17] reported an overall bronchial
anastomotic complication rate of 6.4%, including bronchopleural
and bronchovascular ﬁstula, local necrosis and bronchial rupture.
Merritt et al. [13] registered a bronchopleural ﬁstula rate of 2%,
and Ludwig et al. [19] reported a bronchial anastomotic insufﬁ-
ciency in 6.9% of their patients. In their series of 100 patients,
Kutlu and Goldstraw [20] avoided the wrapping of the bronchial
anastomosis and concluded that the careful handling of the
airway, with the preservation of as much peribronchial tissue as
possible, can avoid the need of any tissue ﬂap on the bronchial
anastomosis. Konstantinou et al. [21] routinely did not perform
any wrapping of the bronchial anastomosis and registered no
anastomotic complication. Accordingly, Rea et al. [22] did not
ﬁnd any signiﬁcant difference in 30-day mortality between
patients with or without pedicled ﬂaps. Moreover, evidence has
also been shown that, in the case of lung transplantation, the in-
cidence of bronchial anastomotic complications is not affected
by wrapping the anastomosis with either omentum or an intern-
al mammary artery pedicle, since there is no improvement in
bronchial healing [14, 15]. This concept could be adopted also
for the anastomoses in course of sleeve resection. In our
experience, we routinely did not use any kind of autogenous
tissue pedicled ﬂap and registered an anastomotic complication
rate of 1%, consisting in an intermediate bronchus narrowing
that didn’t need any surgical treatment. We consider the preser-
vation of an intact peribronchial tissue and a good experience in
the ﬁeld of bronchial anastomosis as the most important factors
for a low anastomotic complication rate.
The safety of sleeve resection after induction therapy remains a
concern. Neoadjuvant chemo- or chemoradiotherapy has been
postulated to have a negative effect on bronchial blood supply,
leading to an increased risk of anastomotic complications [23].
Rea et al. [12] found preoperative radiation as a signiﬁcant risk
factor for anastomotic complications, and Yamamoto et al. [24]
demonstrated that bronchial healing is impaired after chemora-
diation and more than after chemotherapy alone. In our series,
25 patients received preoperative induction therapy, all of them
had neoadjuvant chemotherapy and 5 of them received concur-
rent radiochemotherapy. The most important complication asso-
ciated with the use of a pedicled intercostal muscle ﬂap is
heterotopic calciﬁcation that can cause severe bronchial stenosis,
as reported by Deeb et al. [25]. In our series, we observed no
calciﬁcation and a narrowing of the intermediate bronchus
didn’t need any intervention.
Bronchial sleeve resection has been proved to achieve equal
or better results, if compared with pneumonectomies, also
regarding long-term survival [7, 8]. Yildizeli et al. [17] reported a
5-year survival rate of 53%, whereas Merritt et al. [13] and
Ludwig et al. [19] reported an overall 5-year survival rate of 44
and 39%, respectively. Our 5-year survival rate was 63% in
NSCLC (the lowest long-term survival rate for stage I disease is
probably due to the small number of patients and the long ob-
servation period) and 86% in neuroendocrine tumours.
In conclusion, the postoperative mortality, the incidence of
anastomotic complications and the long-term survival are com-
parable in patients who underwent bronchial sleeve resections
with and without wrapping of the bronchial anastomosis. Sleeve
resection without wrapping the bronchial anastomoses is feasible
and safe in an experienced centre, even in patients who under-
went neoadjuvant chemo- or chemoradiotherapy. Despite the
limitation of our study due to the small number of patients after
radiochemotherapy, we think that wrapping of bronchial anasto-
moses is not routinely mandatory.
Conﬂict of interest: none declared.
Table 4: Postoperative mortality, morbidity and long-term survival after sleeve resection with and without wrapping of the
bronchial anastomosis
Study No. of patients Postoperative mortality (%) Anastomotic complications (%) 5-year survival rate (%) Wrapping
Kutlu and Goldstraw [20] 100 2 8 – −
Rendina et al. [18] 145 3 2.7 37.9 +
Ludwig et al. [19] 116 4.3 6.9 39 +
Yildizeli et al. [17] 218 4.1 6.4 53 +
Rea et al. [12] 199 4.5 5.3 39.7 +
Yamamoto et al. [24] 201 1.4 3.3 57.8 ±
Merritt et al. [13] 196 2 2 44 +
Konstantinou et al. [21] 45 2 0 57 (4-year survival) −
Current study (Zurich) 103 2.9 1 63 (for NSCLC) −
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Wrapping of bronchial anastomoses: something of the past?
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In this study, 103 patients who underwent a variety of sleeve
resections in a centre of excellence are reported [1]. The
reported 30-day mortality was 2.9% and 90-day mortality was
4.8%. Only one patient was lost to follow-up and the 5-year
survival rate was 63% for the patients who were diagnosed
with non-small cell lung cancer (NSCLC). Wrapping of the
bronchial anastomosis with a pedicled tissue ﬂap was not
performed in this series. Only one patient developed a com-
plication of the bronchial anastomosis without a need for
speciﬁc intervention. No bronchial or bronchovascular ﬁstulas
were observed. The authors conclude that sleeve resection
without wrapping of the bronchial anastomosis is a safe
procedure, even after induction chemotherapy or
chemoradiation.
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